Crescendo vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Crescendo

EmergingEnterprise SaaS

Human-in-the-Loop AI Customer Support

Raised $50M at $500M valuation (Oct 2024) led by General Catalyst. Acquired PartnerHero BPO. AI + expert human backstop model. Active 2026 product releases.

About

Crescendo is an AI customer support platform that blends autonomous AI agents with expert human oversight — a hybrid model designed for enterprises that want AI automation without the risk of full autonomy for complex or sensitive customer interactions. The company raised $50 million in total financing at a $500 million valuation led by General Catalyst in October 2024, and reinforced this position with the acquisition of PartnerHero, a 1,800-person business process outsourcing (BPO) company.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.